Back
Centrus Energy 10K Form
Buy
55
LEU
Centrus Energy
Last Price:
78.31
Seasonality Move:
2.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-08 | 10Q | LEU/Centrus Energy Quarterly |
2023-08-04 | 10Q | LEU/Centrus Energy Quarterly |
2023-05-09 | 10Q | LEU/Centrus Energy Quarterly |
2022-11-09 | 10Q | LEU/Centrus Energy Quarterly |
2022-08-05 | 10Q | LEU/Centrus Energy Quarterly |
2022-05-06 | 10Q | LEU/Centrus Energy Quarterly |
Receive LEU News And Ratings
See the #1 stock for the next 7 days that we like better than LEU
LEU Financial Statistics
Sales & Book Value
Annual Sales: | $320.2M |
---|---|
Cash Flow: | $-34.2M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.66 |
Price / Book: | 16.8 |
Profitability
EPS (TTM): | 4.79000 |
---|---|
Net Income (TTM): | $75.8M |
Gross Margin: | $112.1M |
Return on Equity: | 194.26% |
Return on Assets: | 10.99% |
Centrus Energy Earnings Forecast
Key Centrus Energy Financial Ratios
- The Gross Profit Margin over the past 26 years for LEU is 35.01%.
- The Selling, General & Administrative Expenses for LEU have been equal to 11.12% of Gross Profit Margin.
- The Research & Development expenses have been 13.52% of Revenue.
- The Interest Expense is 1.54% of Operating Income.
- The Net Earning history of LEU is 26.36% of Total Revenues.
- Per Share Earnings over the last 26 years have been positive in 14 years.
Centrus Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYAM |
---|---|
Industry: | Oil, Gas & Consumable Fuels |
Sector: | Energy |
Current Symbol: | LEU |
CUSIP: | 15643U |
Website: | centrusenergy.com |
Debt
Debt-to-Equity Ratio: | 2.23 |
---|---|
Current Ratio: | 1.63 |
Quick Ratio: | 0.67 |
Price-to-Earnings
Trailing P/E Ratio: | 14.39 |
---|---|
Forward P/E Ratio: | 28.03 |
LEU Technical Analysis vs Fundamental Analysis
Buy
55
Centrus Energy (LEU)
is a Buy
Is Centrus Energy a Buy or a Sell?
-
Centrus Energy stock is rated a Buy
The current Centrus Energy [LEU] share price is $78.29. The Score for LEU is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.